Private Equity/Consumer, health, RE
PAG (India) logo

PAG (India)

PAG is an Asia-focused alternative manager with private equity, real assets and credit businesses. Its India private-equity activity is led by Nikhil Srivastava and is visible through Nuvama, healthcare and pharmaceutical positions, alongside a broader multi-asset platform.

At a glance

Founded
2002
Footprint
Hong Kong / Mumbai
Stage
Buyout + special sits

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

PAG (India) uses a buyout + special sits approach across Consumer, health, RE.

Current evidence

PAG’s current private-equity page identifies Nuvama Wealth Management and Acme Formulation as India investments. PAG’s 2025 company profile reports more than $55 billion of assets under management and identifies Nikhil Srivastava as a senior investor who has worked across India, Singapore and the US; India-only book size and returns are not publicly disclosed.

Strategy

Buyout + special sits

Sector focus

Consumer, health, RE

Current signal

PAG’s current private-equity page identifies Nuvama Wealth Management and Acme Formulation as India investments. PAG’s 2025 company profile reports more than $55 billion of assets under management and identifies Nikhil Srivastava as a senior investor who has worked across India, Singapore and the US; India-only book size and returns are not publicly disclosed.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →